There are plenty of ASX dividend shares to choose from on the Australian share market.
But which ones could be buys this week?
Two ASX dividend shares that brokers believe investors should be buying right now are listed below. Here's what they are saying about them:
Image source: Getty Images
Deterra Royalties Ltd (ASX: DRR)
The team at Morgan Stanley believes that Deterra Royalties could be an ASX dividend share to buy.
It operates a mining royalty business across a range of commodities, with a primary focus on bulks, base metals, and battery metals. This includes the Mining Area C iron ore operation, which is co-owned with mining behemoth BHP Group Ltd (ASX: BHP).
Morgan Stanley has an overweight rating and a $5.65 price target on its shares.
As for dividends, it is expecting the company to pay fully franked dividends per share of 40.3 cents in FY 2024 and 30.1 cents in FY 2025. Based on the current Deterra Royalties share price of $5.15, this will mean dividend yields of 7.8% and 5.8%, respectively.
NIB Holdings Limited (ASX: NHF)
Over at Goldman Sachs, its analysts think that NIB could be an ASX dividend share to buy.
It is an Australian health insurance company providing health and medical insurance to over one million Australian residents. Goldman likes the company because it "offers defensive exposure to the private health insurance sector which is experiencing favourable operating trend."
Its analysts currently have a buy rating and $8.40 price target on its shares.
As for income, the broker is expecting the private health giant to pay fully franked dividends per share of 29 cents in FY 2024 and 33 cents in FY 2025. Based on the current NIB share price of $7.56, this will mean 3.8% and 4.35%, respectively.
